Orthopedic implant provider China Kanghui files for a $75 million IPO

China Kanghui Holdings, which is a leading China-based manufacturer and marketer of orthopedic implants, filed on Friday with the SEC to raise up to $75 million in an initial public offering. The Changzhou-based company, which was founded in 1997 and booked $29 million in sales over the last 12 months, plans to list on the NYSE under the symbol KH. Morgan Stanley and Piper Jaffray are the lead underwriters on the deal. No pricing terms were disclosed.

Posted By

Josh Sandberg has been recruiting specifically in the musculoskeletal industry for over 8 years. Throughout this time, he has been able to have a positive impact on his client’s businesses. With an educational background in Business Management, Josh is adept to discern which people will be the best fit for the company he is searching for by understanding how candidates will incorporate with the company’s culture and operational nuances. His experience as an executive in a start-up business has granted him the ability to understand what is takes to thrive in a hands–on environment, where desire and dedication are paramount for success.